{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:49:27Z","timestamp":1790495367516,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Centre Of Excellence, National AIDS Control Organization , India","award":["M-18017\/72\/ 2007\/NACO (GF Rd6),"],"award-info":[{"award-number":["M-18017\/72\/ 2007\/NACO (GF Rd6),"]}]},{"name":"HIV drug resistance database project ,Indian Council of Medical Research (ICMR), New Delhi","award":["File No. AMR\/28\/2011-ECD-I"],"award-info":[{"award-number":["File No. AMR\/28\/2011-ECD-I"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-1270-8","type":"journal-article","created":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T06:17:20Z","timestamp":1447481840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Outcome of patients on second line antiretroviral therapy under programmatic condition in India"],"prefix":"10.1186","volume":"15","author":[{"given":"Jaya","family":"Chakravarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Chourasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallav Narayan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarali","family":"Kurle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth P.","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devidas N","family":"Chaturbhuj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhukar","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit Kumar","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabindra Nath","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh S.","family":"Paranjape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,14]]},"reference":[{"key":"1270_CR1","unstructured":"NACO: Annual report 2014\u201315. Department of AIDS Control, Ministry of Health and Family Welfare, Government of India."},{"issue":"8","key":"1270_CR2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1468-1293.2010.00825.x","volume":"11","author":"MC Hosseinipour","year":"2010","unstructured":"Hosseinipour MC, Kumwenda JJ, Weigel R, Brown LB, Mzinganjira D, Mhango B, et al. Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline. HIV Med. 2010;11(8):510\u20138.","journal-title":"HIV Med"},{"issue":"4","key":"1270_CR3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/QAI.0b013e3181bcdac1","volume":"53","author":"MP Fox","year":"2010","unstructured":"Fox MP, Ive P, Long L, Maskew M, Sanne I. High rates of survival, immune reconstitution, and virologic suppression on second-line antiretroviral therapy in South Africa. J Acquir Immune Defic Syndr. 2010;53(4):500\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"1270_CR4","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/QAD.0b013e328351f5b2","volume":"26","author":"O Ajose","year":"2012","unstructured":"Ajose O, Mookerjee S, Mills EJ, Boulle A, Ford N. Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. AIDS. 2012;26(8):929\u201338.","journal-title":"AIDS"},{"issue":"4","key":"1270_CR5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4103\/2229-3485.120170","volume":"4","author":"D Patel","year":"2013","unstructured":"Patel D, Desai M, Shah AN, Dikshit RK. Early outcome of second line antiretroviral therapy in treatment-experienced human immunodeficiency virus positive patients. Perspect Clin Res. 2013;4(4):215\u201320.","journal-title":"Perspect Clin Res"},{"key":"1270_CR6","unstructured":"National AIDS Control program phase IV (2012\u20132017). Strategy document. Department of AIDS Control. Ministry of Health and Family Welfare, Government of India."},{"key":"1270_CR7","volume-title":"Antiretroviral Therapy for HIV Infection in Adults and Adolescents in Resource-Limited Settings","author":"WHO: World Health Organization","year":"2006","unstructured":"WHO: World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents in Resource-Limited Settings. Geneva: Towards Universal Access; 2006."},{"key":"1270_CR8","volume-title":"National AIDS Control Organisation","author":"NACO","year":"2011","unstructured":"NACO. National AIDS Control Organisation. New Delhi, India: Ministry of Health and Family Welfare Government of India. National Guidelines on Second-line ART for adults and adolescents; 2011."},{"issue":"2","key":"1270_CR9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087441","volume":"9","author":"DN Chaturbhuj","year":"2014","unstructured":"Chaturbhuj DN, Nirmalkar AP, Paranjape RS, Tripathy SP. Evaluation of a cost effective in-house method for HIV-1 drug resistance genotyping using plasma samples. PLoS One. 2014;9(2), e87441.","journal-title":"PLoS One"},{"issue":"1","key":"1270_CR10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jviromet.2013.01.001","volume":"189","author":"DN Chaturbhuj","year":"2013","unstructured":"Chaturbhuj DN, Deshmukh PS, Hingankar NK, Siddhaarth K, Deshpande SN, Sen S, et al. Evaluations of an in-house drug resistance method for HIV-1 drug resistance using ViroSeq 2.0 genotyping system as a gold standard. J Virol Methods. 2013;189(1):87\u201392.","journal-title":"J Virol Methods"},{"key":"1270_CR11","unstructured":"Stanford University HIV Drug Resistance Database. http:\/\/hivdb.stanford.edu\/ ."},{"issue":"3","key":"1270_CR12","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jac\/dkp252","volume":"64","author":"M Zazzi","year":"2009","unstructured":"Zazzi M, Prosperi M, Vicenti I, Di Giambenedetto S, Callegaro A, Bruzzone B, et al. Rules-based HIV-1 genotypic resistance interpretation systems predict 8\u00a0week and 24\u00a0week virological antiretroviral treatment outcome and benefit from drug potency weighting. J Antimicrob Chemother. 2009;64(3):616\u201324.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"1270_CR13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/QAD.0b013e32833677ac","volume":"24","author":"J Vingerhoets","year":"2010","unstructured":"Vingerhoets J, Tambuyzer L, Azijn H, Hoogstoel A, Nijs S, Peeters M, et al. Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies. AIDS. 2010;24(4):503\u201314.","journal-title":"AIDS"},{"issue":"3","key":"1270_CR14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058526","volume":"8","author":"AF Schoffelen","year":"2013","unstructured":"Schoffelen AF, Wensing AM, Tempelman HA, Geelen SP, Hoepelman AI, Barth RE. Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa. PLoS One. 2013;8(3):e58526.","journal-title":"PLoS One"},{"key":"1270_CR15","doi-asserted-by":"crossref","first-page":"18449","DOI":"10.7448\/IAS.16.1.18449","volume":"16","author":"S Vallabhaneni","year":"2013","unstructured":"Vallabhaneni S, Chandy S, Heylen E, Ekstrand ML. Evaluation of WHO immunologic criteria for treatment failure: implications for detection of virologic failure, evolution of drug resistance and choice of second-line therapy in India. J Int AIDS Soc. 2013;16:18449.","journal-title":"J Int AIDS Soc"},{"issue":"12","key":"1270_CR16","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/cid\/cir729","volume":"53","author":"HE Rawizza","year":"2011","unstructured":"Rawizza HE, Chaplin B, Meloni ST, Eisen G, Rao T, Sankale JL, et al. Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. Clin Infect Dis. 2011;53(12):1283\u201390.","journal-title":"Clin Infect Dis"},{"issue":"14","key":"1270_CR17","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1097\/QAD.0000000000000349","volume":"28","author":"ML Petersen","year":"2014","unstructured":"Petersen ML, Tran L, Geng EH, Reynolds SJ, Kambugu A, Wood R, et al. Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa. AIDS. 2014;28(14):2097\u2013107.","journal-title":"AIDS"},{"issue":"3","key":"1270_CR18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1056\/NEJMoa1311274","volume":"371","author":"NI Paton","year":"2014","unstructured":"Paton NI, Kityo C, Hoppe A, Reid A, Kambugu A, Lugemwa A, et al. Assessment of second-line antiretroviral regimens for HIV therapy in Africa. N Engl J Med. 2014;371(3):234\u201347.","journal-title":"N Engl J Med"},{"issue":"3","key":"1270_CR19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/jama.2010.980","volume":"304","author":"M Pujades-Rodriguez","year":"2010","unstructured":"Pujades-Rodriguez M, Balkan S, Arnould L, Brinkhof MA, Calmy A. Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries. JAMA. 2010;304(3):303\u201312.","journal-title":"JAMA"},{"key":"1270_CR20","doi-asserted-by":"crossref","first-page":"24861","DOI":"10.3402\/gha.v7.24861","volume":"7","author":"S Khan","year":"2014","unstructured":"Khan S, Das M, Andries A, Deshpande A, Mansoor H, Saranchuk P, et al. Second-line failure and first experience with third-line antiretroviral therapy in Mumbai. India Glob Health Action. 2014;7:24861.","journal-title":"India Glob Health Action"},{"issue":"2","key":"1270_CR21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/QAI.0000000000000411","volume":"68","author":"DC Boettiger","year":"2015","unstructured":"Boettiger DC, Nguyen VK, Durier N, Bui HV, Heng Sim BL, Azwa I, et al. Efficacy of second-line antiretroviral therapy among people living with HIV\/AIDS in Asia: results from the TREAT Asia HIV observational database. J Acquir Immune Defic Syndr. 2015;68(2):186\u201395.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"1270_CR22","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1097\/QAD.0b013e32833a097b","volume":"24","author":"Z El-Khatib","year":"2010","unstructured":"El-Khatib Z, Ekstrom AM, Ledwaba J, Mohapi L, Laher F, Karstaedt A, et al. Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa. AIDS. 2010;24(11):1679\u201387.","journal-title":"AIDS"},{"issue":"4","key":"1270_CR23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/QAI.0b013e31820dc0cc","volume":"56","author":"GU Zyl van","year":"2011","unstructured":"van Zyl GU, van Mens TE, McIlleron H, Zeier M, Nachega JB, Decloedt E, et al. Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting. J Acquir Immune Defic Syndr. 2011;56(4):333\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"1270_CR24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073582","volume":"8","author":"HE Rawizza","year":"2013","unstructured":"Rawizza HE, Chaplin B, Meloni ST, Darin KM, Olaitan O, Scarsi KK, et al. Accumulation of protease mutations among patients failing second-line antiretroviral therapy and response to salvage therapy in Nigeria. PLoS One. 2013;8(9):e73582.","journal-title":"PLoS One"},{"issue":"7","key":"1270_CR25","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/cid\/cir967","volume":"54","author":"S Saravanan","year":"2012","unstructured":"Saravanan S, Vidya M, Balakrishnan P, Kantor R, Solomon SS, Katzenstein D, et al. Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern India. Clin Infect Dis. 2012;54(7):995\u20131000.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1270_CR26","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1371\/journal.pmed.0040036","volume":"4","author":"M Nijhuis","year":"2007","unstructured":"Nijhuis M, van Maarseveen NM, Lastere S, Schipper P, Coakley E, Glass B, et al. A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism. PLoS Med. 2007;4(1):e36.","journal-title":"PLoS Med"},{"issue":"11","key":"1270_CR27","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/QAD.0b013e3283398216","volume":"24","author":"RK Gupta","year":"2010","unstructured":"Gupta RK, Kohli A, McCormick AL, Towers GJ, Pillay D, Parry CM. Full-length HIV-1 Gag determines protease inhibitor susceptibility within in vitro assays. AIDS. 2010;24(11):1651\u20135.","journal-title":"AIDS"},{"key":"1270_CR28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1742-4690-9-63","volume":"9","author":"A Fun","year":"2012","unstructured":"Fun A, Wensing AM, Verheyen J, Nijhuis M. Human Immunodeficiency Virus Gag and protease: partners in resistance. Retrovirology. 2012;9:63.","journal-title":"Retrovirology"},{"issue":"1","key":"1270_CR29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/aid.2009.0102","volume":"26","author":"A Gupta","year":"2010","unstructured":"Gupta A, Saple DG, Nadkarni G, Shah B, Vaidya S, Hingankar N, et al. One-, two-, and three-class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India. AIDS Res Hum Retroviruses. 2010;26(1):25\u201331.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"1270_CR30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3329\/jhpn.v29i4.8444","volume":"29","author":"JM Nwobegahay","year":"2011","unstructured":"Nwobegahay JM, Bessong PO, Masebe TM, Mavhandu LG, Iweriebor BC, Selabe G. Prevalence of antiretroviral drug resistance mutations and HIV-I subtypes among newly-diagnosed drug-naive persons visiting a voluntary testing and counselling centre in northeastern South Africa. J Health Popul Nutr. 2011;29(4):303\u20139.","journal-title":"J Health Popul Nutr"},{"issue":"4","key":"1270_CR31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/aid.2005.21.301","volume":"21","author":"P Balakrishnan","year":"2005","unstructured":"Balakrishnan P, Kumarasamy N, Kantor R, Solomon S, Vidya S, Mayer KH, et al. HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India. AIDS Res Hum Retroviruses. 2005;21(4):301\u20135.","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1270-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T12:57:54Z","timestamp":1718197074000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2334\/15\/517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,14]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1270"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-1270-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,14]]},"article-number":"517"}}